ACBM
Acro Biomedical Co., Ltd.
$0.03
+0.00 (+0.00%)
At close · Jul 8
Market Cap
$1.56M
Shares
60,042,000
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.03
Open$0.03
Day$0.03–0.03
52W$0.00–0.10
Avg vol 30d17
Short int4 · 0.0% float · 1000.0d
DataJan 2020–Jul 2026
Filing10-Q · May 5
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Sell
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Low
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+56%
above
Price vs 50-day avg
0%
above
RSI (14)
100
overbought
MACD trend
Negative
52-week position
25%
mid-range
Momentum
relative strength
1-month return
0%
trailing
6-month return
+17%
trailing
YTD return
+17%
this year
Relative strength
+10%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
3078%
annualized · 1-yr
Max drawdown
0%
past year
ATR
0.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 5, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+56%
Bullish
Price vs 50-day avg
0%
Neutral
RSI (14)
100
Bearish
MACD trend
Negative
Bearish
52-week position
25%
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $0
Now $0 · 25%
52-wk high $0
vs 200-day avg +56%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ACBM
this stock
Acro Biomedical Co., Ltd.
|
$1.56M | +17.1% | — | — | 0.0% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | +0.0% | — | 100.2 | — |
|
XXI
Twenty One Capital, Inc.
|
$3.40B | -40.2% | — | — | 0.9% |
|
CCXI
Churchill Capital Corp XI
|
$849.98M | — | — | — | 0.0% |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$643.37M | +2.0% | — | — | 0.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ACBM | +0.0% | +0.0% | +17.1% | +0.0% | +17.1% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +0.2% | -0.8% | +9.7% | +0.2% | +7.8% |